DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
112 hedge funds and large institutions have $840M invested in Dicerna Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 29 increasing their positions, 33 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
12% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 33
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
112
Holding in Top 10
3
Calls
$214K
Puts
$1K
Top Buyers
| 1 | +$25.3M | |
| 2 | +$16.1M | |
| 3 | +$10.3M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.28M |
| 5 |
Renaissance Technologies
New York
|
+$6.97M |
Top Sellers
| 1 | -$21.7M | |
| 2 | -$12M | |
| 3 | -$7.92M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.06M |
| 5 |
Millennium Management
New York
|
-$5.58M |